Lux Health Tech Acquisition Corp.
Status: Liquidated
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $345.00M |
---|---|
IPO Date | Oct 27, 2020 |
CEO | Josh DeFonzo |
Left Lead | Credit Suisse |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Healthcare and technology |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Closing Date | Oct 28, 2022 |
LUXA
LUXAU
LUXAW
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Lux Health Tech Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 11 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Peter Hébert | 43 | Chairman |
Josh DeFonzo | 39 | CEO and Director |
Segolene Scarborough | 41 | CFO and Treasurer |
Bijan Salehizadeh | 47 | Director |
Joseph Robert “Bob” Kerrey | 76 | Director |
Fred Moll | 68 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Credit Suisse | BR | 24,000,000 | units |
Stifel Nicolaus | 6,000,000 | ||
30,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 11 filings.